---
schema_version: "secwatch.filing_event.v1"
accession: "0001790340-26-000099"
form_type: "8-K"
ticker: "IMRX"
cik: "0001790340"
company_name: "Immuneering Corp"
filed_at: "2026-11-09T21:16:03+00:00"
generated_at: "2026-11-09T21:17:01.986607+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Immuneering adds Grant C. Bogle to board as Class III director effective Nov 9, 2026

## Summary
- Board of Immuneering Corporation appointed Grant C. Bogle, MBA, as a Class III director on November 9, 2026.
- Bogle has not been appointed to any board committee at this time.
- Bogle will be compensated per the company's standard non-employee director arrangements and signed the standard director/officer indemnification agreement.
- No arrangement or understanding existed pursuant to which Bogle was elected as a director.

## SEC filing metadata
- accession: 0001790340-26-000099
- form_type: 8-K
- ticker: IMRX
- cik: 0001790340
- company_name: Immuneering Corp
- filed_at: 2026-11-09T21:16:03+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1790340/000179034026000099/0001790340-26-000099-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1790340/000179034026000099/imrx-20261109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001790340-26-000099
- JSON: https://secwatch.observer/filing/0001790340-26-000099.json
- Plain text: https://secwatch.observer/filing/0001790340-26-000099.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.